European Life Technologies
genosmart DX offers a full-service solution for personalized next-generation cancer care, focusing on genetic diagnostics and liquid biopsy. They provide diagnostic kits for sample preparation, NGS sequencing capacity, and bioinformatics services for in-depth analysis and therapeutic decision support. Their products include various DNA and RNA panels tailored for different cancer types such as lung, colon, breast/ovary, prostate, and skin/melanoma. The company is also developing an AI-powered breast cancer assay and a non-invasive urine test for prostate cancer detection. Their approach emphasizes early detection, monitoring, and personalized treatment strategies through advanced molecular technologies.
European Life Technologies
genosmart DX offers a full-service solution for personalized next-generation cancer care, focusing on genetic diagnostics and liquid biopsy. They provide diagnostic kits for sample preparation, NGS sequencing capacity, and bioinformatics services for in-depth analysis and therapeutic decision support. Their products include various DNA and RNA panels tailored for different cancer types such as lung, colon, breast/ovary, prostate, and skin/melanoma. The company is also developing an AI-powered breast cancer assay and a non-invasive urine test for prostate cancer detection. Their approach emphasizes early detection, monitoring, and personalized treatment strategies through advanced molecular technologies.